Co announces that the FDA has granted tentative approval for the co's Abbreviated New Drug Application to market its generic version of GlaxoSmithKline's (GSK) antiviral product Valtrex Tablets. Final ...
Ranbaxy Laboratories announces it has reached an agreement with GlaxoSmithKline (GSK) resulting in a dismissal of their U.S. litigation with regard to Valtrex. The lawsuit in the U.S. was related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results